These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37713930)

  • 1. Association between post-operative hPG
    Doucet L; Cailleteau A; Vaugier L; Gourmelon C; Bureau M; Salaud C; Roualdes V; Samarut E; Aumont M; Zenatri M; Loussouarn D; Quillien V; Bocquet F; Payen-Gay L; Joubert D; Prieur A; Robert M; Frenel JS
    ESMO Open; 2023 Oct; 8(5):101626. PubMed ID: 37713930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma hPG
    Dupuy M; Iltache S; Rivière B; Prieur A; Pageaux GP; Bedoya JU; Faure S; Guillaumée H; Assenat E
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Plasma hPG
    Kohli M; Tan W; Vire B; Liaud P; Blairvacq M; Berthier F; Rouison D; Garnier G; Payen L; Cousin T; Joubert D; Prieur A
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma hPG
    Prieur A; Harper A; Khan M; Vire B; Joubert D; Payen L; Kopciuk K
    BMC Cancer; 2023 Apr; 23(1):305. PubMed ID: 37016331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method to detect hPG
    Cappellini M; Flaceliere M; Saywell V; Soule J; Blanc E; Belouin F; Ortiz E; Canterel-Thouennon L; Poupeau S; Tigrett S; Vire B; Liaud P; Blairvacq M; Joubert D; Prieur A
    Anal Methods; 2021 Oct; 13(38):4468-4477. PubMed ID: 34494619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hPG
    Chauhan A; Prieur A; Kolesar J; Arnold S; Payen L; Mahi Y; Vire B; Sands M; Evers BM; Joubert D; Anthony L
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients.
    You B; Mercier F; Assenat E; Langlois-Jacques C; Glehen O; Soulé J; Payen L; Kepenekian V; Dupuy M; Belouin F; Morency E; Saywell V; Flacelière M; Elies P; Liaud P; Mazard T; Maucort-Boulch D; Tan W; Vire B; Villeneuve L; Ychou M; Kohli M; Joubert D; Prieur A
    EBioMedicine; 2020 Jan; 51():102574. PubMed ID: 31877416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [hPG
    You B; Assenat E; Payen L; Mazard T; Glehen O; Calattini S; Villeneuve L; Lescuyer G; Vire B; Ychou M
    Bull Cancer; 2022 Jun; 109(6):707-713. PubMed ID: 35597620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hPG
    Casile M; Passildas J; Vire B; Molnar I; Durando X
    Front Neurol; 2022; 13():1073476. PubMed ID: 36712425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
    Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; de Souza P
    PLoS One; 2021; 16(6):e0252614. PubMed ID: 34138894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
    Molinaro AM; Hervey-Jumper S; Morshed RA; Young J; Han SJ; Chunduru P; Zhang Y; Phillips JJ; Shai A; Lafontaine M; Crane J; Chandra A; Flanigan P; Jahangiri A; Cioffi G; Ostrom Q; Anderson JE; Badve C; Barnholtz-Sloan J; Sloan AE; Erickson BJ; Decker PA; Kosel ML; LaChance D; Eckel-Passow J; Jenkins R; Villanueva-Meyer J; Rice T; Wrensch M; Wiencke JK; Oberheim Bush NA; Taylor J; Butowski N; Prados M; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Berger MS
    JAMA Oncol; 2020 Apr; 6(4):495-503. PubMed ID: 32027343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
    Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP
    Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.
    Guden M; Ayata HB; Ceylan C; Kilic A; Engin K
    Indian J Cancer; 2016; 53(3):382-386. PubMed ID: 28244465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.
    Marini A; Dobran M; Aiudi D; Pesaresi A; di Somma LGM; Iacoangeli M
    Clin Neurol Neurosurg; 2020 Oct; 197():106162. PubMed ID: 32890893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Spinal Cord Glioblastoma Multiforme: A Retrospective Study of Patients at a Single Institution.
    Cheng X; Lou S; Huang S; Chen H; Liu J
    World Neurosurg; 2017 Oct; 106():113-119. PubMed ID: 28377242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models.
    Choi Y; Nam Y; Jang J; Shin NY; Lee YS; Ahn KJ; Kim BS; Park JS; Jeon SS; Hong YG
    Eur Radiol; 2021 Apr; 31(4):2084-2093. PubMed ID: 33006658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
    Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
    Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.